Breast cancer patients still have risk of relapse after 5 years of systemic therapy
Breast cancer survivors continue to have a substantial risk of disease recurrence after five years of systemic therapy, according to a study published in the August 12 online issue of the Journal of the National Cancer Institute.
Linear Mode
